Official data from Switzerland has revealed that the European nation has recorded a disturbing 73 percent spike in cancer cases since 2020.
The spike was revealed in a bombshell report from Helsana, a major Swiss health insurance company.
Since 2016 the number of patients receiving cancer treatments has decreased.
However, something changed in 2021 and 2022 that saw cancer cases skyrocket to unprecedented levels.
In 2021, Helsana’s data shows there was a dramatic increase of 73% compared to 2020 in the number of patients receiving cancer treatments.
And the high number of cancer patients continued in 2022 with an increase of 74% compared to 2020.
Switzerland began its mass covid vaccination campaign on 23 December 2020.
The Helsana Drug Report has been published annually for the past 10 years.
It analyses the Swiss pharmaceutical market and provides insights into the cost and consumption of drugs.
It is prepared in cooperation with the University Hospital Basel and the Institute of Pharmaceutical Medicine of the University of Basel.
The latest report, published on 30 November 2023, shows data for the year 2022.
The information from the Helsana Drug Report was highlighted by Konstantin Beck, a health economist at the University of Lucerne, in a video